Several studies have demonstrated that treatment with enzyme-inducing antiepileptic drugs is associated with increased serum lipid levels. Eslicarbazepine acetate (ESL) is a novel antiepileptic drug specifically designed with the objective to identify carbamazepine and oxcarbazepine analogues with favorable pharmacodynamic and pharmacokinetic profiles. The present study aimed to assess the changes in lipid profile and sodium levels in patients with epilepsy taking ESL as adjunctive therapy.

Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy / Pulitano, Patrizia; Franco, Valentina; Mecarelli, Oriano; Brienza, Marianna; Davassi, Chiara; Russo, Emilio. - In: SEIZURE. - ISSN 1059-1311. - 53:(2017). [10.1016/j.seizure.2017.09.023]

Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy

Pulitano, Patrizia;Mecarelli, Oriano;Brienza, Marianna;Davassi, Chiara;
2017

Abstract

Several studies have demonstrated that treatment with enzyme-inducing antiepileptic drugs is associated with increased serum lipid levels. Eslicarbazepine acetate (ESL) is a novel antiepileptic drug specifically designed with the objective to identify carbamazepine and oxcarbazepine analogues with favorable pharmacodynamic and pharmacokinetic profiles. The present study aimed to assess the changes in lipid profile and sodium levels in patients with epilepsy taking ESL as adjunctive therapy.
2017
cholesterol; epilepsy; eslicarbazepine acetate; hyponatremia; LDL; lipids
01 Pubblicazione su rivista::01a Articolo in rivista
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy / Pulitano, Patrizia; Franco, Valentina; Mecarelli, Oriano; Brienza, Marianna; Davassi, Chiara; Russo, Emilio. - In: SEIZURE. - ISSN 1059-1311. - 53:(2017). [10.1016/j.seizure.2017.09.023]
File allegati a questo prodotto
File Dimensione Formato  
Pulitano_effects-eslicarbazepine-acetate_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 445.68 kB
Formato Adobe PDF
445.68 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1076677
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact